Health Canada approves Lilly's Mounjaro to reduce cardiovascular risk in adults with type 2 diabetes
LLY•Health Canada approved Eli Lilly's Mounjaro to reduce cardiovascular risk in adults with type 2 diabetes and established cardiovascular disease.
1. Canadian approval
Health Canada approved Mounjaro for cardiovascular risk reduction in adults with type 2 diabetes and established cardiovascular disease.




